complacency has caused the downfall of many - no one or no entity is safe from that IMO. one patent expires next year and competitors and like products will IMO create issues going forward - I do not believe this trotted out line that there is nothing like it and there won't be. however investors are obviously shy to buy in because of the limited (oh so limited IMO) prospects of this once bio darling. Since the leaving of RT not much has occurred IMO. only investors that are attempting to spruik the "dividend" potential are posting here and again IMO that is shortsightedness as capital appreciation is limited and the need to have a decent dividend is glaringly obvious to keep some form of investor interest here. all IMO.
Add to My Watchlist
What is My Watchlist?
